ATP6V1F is overexpressed in hepatocellular carcinoma (HCC), and this overexpression is associated with poor prognosis, immune cell infiltration, and elevated expression of immune checkpoints [26]. The gene discussed is ATP6V1F; the disease is hepatocellular carcinoma.